The 7 AI Governance Questions Every Hospital Board Should Ask

Artificial intelligence is rapidly entering clinical practice. Hospitals are deploying AI systems in radiology, clinical decision support, triage systems and operational analytics.

With the introduction of the European Union Artificial Intelligence Act, healthcare organisations must ensure that these systems are deployed responsibly and under appropriate governance structures.

For hospital leadership, the question is no longer whether AI will be used, but how it will be governed.

Below are seven governance questions hospital boards should ask when overseeing artificial intelligence systems.

Many hospitals deploy AI tools without maintaining a central inventory.

Boards should ask:

• —Which AI systems are currently used?
• —In which clinical workflows?
• —Who approved their deployment?

Maintaining a registry of AI systems is often the first step toward responsible oversight.

For hospitals seeking a structured approach to AI system registration, the Clinical AI Registry platform provides a standardised framework designed specifically for healthcare organisations navigating EU AI Act requirements.

Without visibility into where AI influences clinical processes, hospitals cannot assess their governance obligations or regulatory exposure.

Under the EU AI Act, certain AI systems are classified as high-risk.

This may include systems used for:

• —clinical decision support
• —diagnosis
• —patient triage
• —treatment recommendations

Hospitals must understand whether their AI deployments fall into this category.

High-risk classification triggers specific obligations related to risk management, data governance, transparency, human oversight, and post-market surveillance.

Boards should ensure that clinical and technical teams have conducted risk assessments to determine which systems require enhanced governance.

For a comprehensive overview of AI governance frameworks, hospital leadership may find value in reviewing the Clinical AI Governance: A Practical Guide for Hospitals, which provides detailed guidance on risk classification processes and governance implementation.

AI governance requires clear accountability.

Boards should ensure that responsibility for AI oversight is defined across:

• —clinical leadership
• —digital health teams
• —compliance and risk management

Without defined accountability, governance gaps may emerge.

Many hospitals establish multidisciplinary AI governance committees bringing together medical directors, chief information officers, chief medical information officers, patient safety officers, and legal/compliance teams.

Boards should confirm that governance structures are formalised, resourced, and empowered to make decisions about AI deployment and oversight.

AI models may change behaviour as environments evolve.

Hospitals should have processes to monitor:

• —accuracy and reliability
• —unexpected outputs
• —performance drift

Monitoring ensures that AI continues to operate safely after deployment.

Unlike traditional software, AI systems may exhibit performance degradation when clinical populations shift, data distributions change, or when deployed in contexts different from their original training environments.

Boards should ask:

• —What monitoring mechanisms are in place?
• —How frequently are high-risk systems reviewed?
• —Who is responsible for acting on performance concerns?

Continuous surveillance is essential for patient safety and regulatory compliance.

Human oversight remains a core principle of responsible AI.

Clinicians must be able to:

• —understand the role of AI in decision processes
• —question algorithmic recommendations
• —override AI outputs when necessary

Maintaining clinical judgement is essential.

The EU AI Act emphasises the importance of human oversight for high-risk systems. Healthcare organisations must ensure that AI tools support rather than replace clinical expertise.

Boards should confirm that:

• —Clinicians receive training on AI system capabilities and limitations
• —Override mechanisms are accessible and documented
• —AI outputs are presented as decision support, not prescriptive directives

Transparency and clinical autonomy protect both patient safety and professional accountability.

Regulatory frameworks increasingly require documentation of:

• —risk assessments
• —governance structures
• —monitoring activities

Hospitals should maintain records demonstrating responsible oversight of AI systems.

Documentation serves multiple purposes:

• —Internal governance accountability
• —Regulatory inspection readiness
• —Legal risk management
• —Institutional knowledge preservation

Boards should ask:

• —What documentation standards exist for AI governance?
• —Where are governance records maintained?
• —Are documentation practices audit-ready?

Comprehensive documentation demonstrates due diligence and institutional commitment to responsible AI deployment.

For hospitals seeking structured governance infrastructure, Lifecycle Governance provides platforms designed specifically to support healthcare organisations in establishing documentation systems aligned with EU AI Act requirements.

Artificial intelligence adoption in healthcare will continue to grow.

Boards should consider:

• —long-term governance frameworks
• —organisational AI policies
• —oversight mechanisms for future deployments

Preparing early enables hospitals to adopt innovation responsibly.

As AI capabilities advance, hospitals will face decisions about:

• —Integrating generative AI into clinical documentation
• —Deploying predictive analytics for population health
• —Adopting ambient clinical intelligence systems
• —Implementing AI-driven diagnostic tools

Governance frameworks built today provide the foundation for evaluating and integrating emerging technologies safely.

Boards should ensure that governance capacity grows alongside AI adoption, with ongoing investment in expertise, infrastructure, and institutional processes.

These seven questions provide a framework for hospital boards to assess their institution's readiness for responsible AI governance.

Addressing these questions enables leadership to:

Ensure Patient Safety Systematic oversight reduces risks associated with algorithmic errors or unexpected AI behaviour.

Meet Regulatory Obligations Proactive governance positions hospitals favourably for EU AI Act compliance and regulatory inspection.

Maintain Clinical Trust Transparent governance processes support clinician confidence in AI tools and preserve professional autonomy.

Enable Innovation Clear oversight frameworks allow safe exploration of beneficial technologies while managing risks.

Protect Institutional Reputation Governance failures, particularly those affecting patient outcomes, carry significant reputational consequences.

Boards overseeing organisations deploying or planning to deploy clinical AI systems should consider:

1. Request a Governance Briefing Ask executive leadership to present current AI governance structures, identifying systems in use, risk classifications, and oversight mechanisms.

2. Establish Board-Level Oversight Ensure that AI governance is included in board-level risk and quality committee agendas.

3. Allocate Resources Confirm that governance frameworks are adequately resourced with personnel, technology platforms, and ongoing operational support.

4. Engage External Expertise Consider engaging external advisors with expertise in healthcare AI governance and EU regulatory frameworks.

5. Monitor Regulatory Developments Ensure that governance teams track evolving guidance from national competent authorities and regulatory bodies.

Artificial intelligence offers powerful opportunities to improve healthcare delivery. However, the benefits of AI depend on responsible governance.

Hospitals that begin building governance structures today will be better prepared for the regulatory landscape and better positioned to integrate AI safely into clinical practice.

Hospital boards play a critical role in ensuring that AI technologies are deployed transparently, responsibly, and under appropriate institutional oversight.

By asking these seven questions, leadership can assess governance readiness and take concrete steps toward establishing frameworks that protect patients, support clinicians, and enable innovation.

Author Dr. Rebindrenath R. Goerdin Founder — Lifecycle Governance™